BOOTHBAY FUND MANAGEMENT, LLC - PROQR THRAPEUTICS N V ownership

PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 49 filers reported holding PROQR THRAPEUTICS N V in Q4 2022. The put-call ratio across all filers is 1.72 and the average weighting 0.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of PROQR THRAPEUTICS N V
ValueSharesWeighting
Q3 2023$124,469
-19.8%
95,7450.0%0.00%0.0%
Q2 2023$155,107
-23.9%
95,7450.0%0.00%
-25.0%
Q1 2023$203,937
-39.0%
95,745
+6.0%
0.00%
-50.0%
Q4 2022$334,055
+119.8%
90,285
+396.3%
0.01%
+100.0%
Q3 2021$152,000
-41.3%
18,191
-52.6%
0.00%
-50.0%
Q2 2021$259,000
-27.5%
38,408
+6.5%
0.01%
-74.2%
Q4 2019$357,00036,0510.03%
Other shareholders
PROQR THRAPEUTICS N V shareholders Q4 2022
NameSharesValueWeighting ↓
M28 Capital Management LP 1,910,600$2,483,7802.85%
Privium Fund Management B.V. 5,344,446$6,947,7802.07%
DAFNA Capital Management LLC 940,582$1,222,7570.38%
Monaco Asset Management SAM 377,517$490,7720.15%
EcoR1 Capital, LLC 2,980,016$3,874,0210.13%
Ikarian Capital, LLC 472,625$614,4120.07%
FRANKLIN STREET ADVISORS INC /NC 150,000$1950.02%
ADAGE CAPITAL PARTNERS GP, L.L.C. 3,625,467$4,713,1070.01%
GSA CAPITAL PARTNERS LLP 74,084$960.01%
UBS OCONNOR LLC 189,328$246,1260.01%
View complete list of PROQR THRAPEUTICS N V shareholders